Switzerland· 68920001
Triumeq, Tabletten zur Herstellung einer Suspension zum Einnehmen
A lamivudine, abacavir and dolutegravir product containing dolutegravirum, abacavirum, lamivudinum, registered in Switzerland by ViiV Healthcare GmbH and dispensed under Swissmedic category A. The same ATC class is registered in 13 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Lamivudine, abacavir and dolutegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR13 (lamivudine, abacavir and dolutegravir), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Lamivudine, abacavir and dolutegravir · ATC J05AR13
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- dolutegravirum, abacavirum, lamivudinum
- Manufacturer
- ViiV Healthcare GmbH
- Country
- Switzerland (CH)
- ATC code
- J05AR13
- ATC class
- Lamivudine, abacavir and dolutegravir
- Swissmedic category
- A
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for lamivudine, abacavir and dolutegravir.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lamivudine, abacavir and dolutegravir · interactions on record
2 records
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Lamivudine, abacavir and dolutegravir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTriumeq2care4 ApS
- CzechiaTRIUMEQViiV Healthcare BV, Amersfoort
- SpainTRIUMEQ 5 MG/60 MG/30 MG COMPRIMIDOS DISPERSABLESViiv Healthcare B.V.
- FranceTRIUMEQ 5 mg/60 mg/30 mg, comprimé dispersibleVIIV HEALTHCARE (PAYS-BAS)
- United KingdomTriumeq 50mg/600mg/300mg tabletsViiV Healthcare UK Ltd
- IrelandTriumeq 5 mg/60 mg/30 mg dispersible tabletsViiV Healthcare BV
- IcelandTriumeqViiV Healthcare BV
- NetherlandsTriumeq 5 mg/ 60 mg/ 30 mg dispergeerbare tablettenViiV Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Iceland · Triumeq
- Liechtenstein · Triumeq
- Malta · Dolutegravir/Abacavir/Lamivudine Pharos
- Norway · Triumeq
- Portugal · Dolutegravir/Abacavir/Lamivudine Pharos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2e310483-cdad-4452-8e6a-cfe64fbd9a77 GET /v1/drugs/2e310483-cdad-4452-8e6a-cfe64fbd9a77?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about lamivudine, abacavir and dolutegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.